CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 46 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $195,000 | +25.0% | 2,900 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $156,000 | +20.9% | 2,900 | 0.0% | 0.00% | – |
Q2 2014 | $129,000 | +27.7% | 2,900 | 0.0% | 0.00% | – |
Q1 2014 | $101,000 | +20.2% | 2,900 | 0.0% | 0.00% | – |
Q4 2013 | $84,000 | -1.2% | 2,900 | 0.0% | 0.00% | – |
Q3 2013 | $85,000 | +26.9% | 2,900 | 0.0% | 0.00% | – |
Q2 2013 | $67,000 | – | 2,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |